Working… Menu

Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial (BRILLIANT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02655536
Recruitment Status : Unknown
Verified July 2018 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
First Posted : January 14, 2016
Last Update Posted : July 10, 2018
Information provided by (Responsible Party):
National Taiwan University Hospital

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : December 2019